(Q58704494)

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Worldwide trends in mortality from biliary tract malignancies

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Descriptive epidemiology of cholangiocarcinoma in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Molecular pathology of biliary tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Role of epigenetic alterations in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

The role of the NKG2D receptor for tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Disrupted transforming growth factor-beta signaling and deregulated growth in human biliary tract cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

COX-2: a molecular target for colorectal cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Identification of oxysterols in human bile and pigment gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

AKT plays a central role in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

The pathobiology of biliary epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

mir-29 regulates Mcl-1 protein expression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Leptin enhances cholangiocarcinoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F630543

Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169310

The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169310

Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and -3.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169310

Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169310

Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169310

Tamoxifen-mediated growth inhibition of human cholangiocarcinoma

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169310

Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat

30 November 2018

1 reference

12 December 2020

1 reference

12 December 2020

Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9

1 reference

12 December 2020

Expression and antitumor effects of TRAIL in human cholangiocarcinoma

1 reference

12 December 2020

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

12 December 2020

Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers

1 reference

12 December 2020

Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma

1 reference

12 December 2020

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms

1 reference

12 December 2020

Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells

1 reference

12 December 2020

Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma

1 reference

12 December 2020